186 related articles for article (PubMed ID: 15855811)
1. Cancer-related anemia: pathogenesis, prevalence and treatment.
Birgegård G; Aapro MS; Bokemeyer C; Dicato M; Drings P; Hornedo J; Krzakowski M; Ludwig H; Pecorelli S; Schmoll H; Schneider M; Schrijvers D; Shasha D; Van Belle S
Oncology; 2005; 68 Suppl 1():3-11. PubMed ID: 15855811
[TBL] [Abstract][Full Text] [Related]
2. Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.
Cortesi E; Gascón P; Henry D; Littlewood T; Milroy R; Pronzato P; Reinhardt U; Shasha D; Thatcher N; Wilkinson P
Oncology; 2005; 68 Suppl 1():22-32. PubMed ID: 15855813
[TBL] [Abstract][Full Text] [Related]
3. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
Kosmidis P; Krzakowski M;
Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
[TBL] [Abstract][Full Text] [Related]
4. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.
Barrett-Lee P; Bokemeyer C; Gascón P; Nortier JW; Schneider M; Schrijvers D; Van Belle S;
Oncologist; 2005 Oct; 10(9):743-57. PubMed ID: 16249356
[TBL] [Abstract][Full Text] [Related]
5. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
Ludwig H; Van Belle S; Barrett-Lee P; Birgegård G; Bokemeyer C; Gascón P; Kosmidis P; Krzakowski M; Nortier J; Olmi P; Schneider M; Schrijvers D
Eur J Cancer; 2004 Oct; 40(15):2293-306. PubMed ID: 15454256
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cancer-related anemia with epoetin alfa: a review.
Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
[TBL] [Abstract][Full Text] [Related]
7. Optimizing hemoglobin levels and beyond: strength for living and meaningful survival?
Dicato M
Oncology; 2005; 68 Suppl 1():1-2. PubMed ID: 15855810
[No Abstract] [Full Text] [Related]
8. Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):65-72. PubMed ID: 17237894
[TBL] [Abstract][Full Text] [Related]
9. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
10. Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.
Barrett-Lee PJ; Ludwig H; Birgegård G; Bokemeyer C; Gascón P; Kosmidis PA; Krzakowski M; Nortier JW; Kongable G; Schneider M; Schrijvers D; Van Belle SJ;
Oncology; 2006; 70(1):34-48. PubMed ID: 16493206
[TBL] [Abstract][Full Text] [Related]
11. Evolving treatment strategies for anaemia in cancer: experience with epoetin beta.
Aapro M; San Miguel J
Oncology; 2004; 67 Suppl 1():17-22. PubMed ID: 15486449
[TBL] [Abstract][Full Text] [Related]
12. Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey.
Michon J
Med Pediatr Oncol; 2002 Oct; 39(4):448-50. PubMed ID: 12203661
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin is a novel therapeutic option in the treatment of anemia caused by small cell lung cancer].
Tamási L; Bohács A; Wollák A; Magyar P
Magy Onkol; 2006; 50(3):243-6. PubMed ID: 17099785
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
Shasha D; George MJ; Harrison LB
Cancer; 2003 Sep; 98(5):1072-9. PubMed ID: 12942577
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and therapy of renal anemia].
Szegedi J
Orv Hetil; 2008 Feb; 149(6):251-5. PubMed ID: 18238714
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
17. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
18. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
19. The causes and prognostic significance of low hemoglobin levels in tumor patients.
Manegold C
Strahlenther Onkol; 1998 Dec; 174 Suppl 4():17-9. PubMed ID: 9879342
[TBL] [Abstract][Full Text] [Related]
20. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
